You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CONIVAPTAN HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for conivaptan hydrochloride and what is the scope of patent protection?

Conivaptan hydrochloride is the generic ingredient in two branded drugs marketed by Cumberland and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for CONIVAPTAN HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 98
Clinical Trials: 21
Patent Applications: 222
What excipients (inactive ingredients) are in CONIVAPTAN HYDROCHLORIDE?CONIVAPTAN HYDROCHLORIDE excipients list
DailyMed Link:CONIVAPTAN HYDROCHLORIDE at DailyMed
Recent Clinical Trials for CONIVAPTAN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brooke Army Medical CenterPhase 3
Ottawa Hospital Research InstitutePhase 3
University of OttawaPhase 3

See all CONIVAPTAN HYDROCHLORIDE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for CONIVAPTAN HYDROCHLORIDE

US Patents and Regulatory Information for CONIVAPTAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cumberland VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-002 Oct 8, 2008 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cumberland VAPRISOL conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-001 Dec 29, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CONIVAPTAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cumberland VAPRISOL conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-001 Dec 29, 2005 ⤷  Sign Up ⤷  Sign Up
Cumberland VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-002 Oct 8, 2008 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.